|
FY2025
12 months to Nov 30, 2025
|
FY2024
12 months to Nov 30, 2024
|
FY2023
12 months to Nov 30, 2023
|
FY2022
12 months to Nov 30, 2022
|
FY2021
12 months to Nov 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Processing and Storage Fees | |||||
| Public Banking | |||||
| Product | |||||
| Total revenue | |||||
| Costs and Expenses: | |||||
| Cost of sales | |||||
| Selling, general and administrative expenses | |||||
| Impairment of public inventory | |||||
| Impairment of investment | |||||
| Impairment of Duke assets | |||||
| Change in fair value of contingent consideration | |||||
| Research, development and related engineering | |||||
| Depreciation and amortization | |||||
| Total costs and expenses | |||||
| Operating Income | |||||
| Other Income (Expense): | |||||
| (Losses) gains on marketable securities | |||||
| Gain on sale of property and equipment | |||||
| Other income | |||||
| Interest expense | |||||
| Total other (expense) income | |||||
| (Loss) income before income tax expense | |||||
| Income tax expense | |||||
| Net (loss) income | |||||
| Net (loss) income per common share - basic | |||||
| Weighted average common shares outstanding - basic | |||||
| Net (loss) income per common share - diluted | |||||
| Weighted average common shares outstanding - diluted |
Loading...